DCLK3 and colorectal cancer: reported that the non-coding variant, rs1800734 promotes the progression of colorectal cancer by targeting DCLK3, suggesting the important role of overexpressing DCLK3 in the progression of cancer via epithelial-to-mesenchymal transition (32).